Evidence map›Paper›PMID 40113830›Full record

ArticleScientific reports2025

Germ cell depletion using HSV-TK in mouse testes.

Constance Dollet, Miyuki Shindo, Shun Takahashi, Kento Ito, Tomoo Eto, Toshiaki Watanabe

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Constance Dollet *Center for Regenerative Medicine, National Center for Child Health and Development, Tokyo, 157-8535, Japan.
Miyuki Shindo *Center for Regenerative Medicine, National Center for Child Health and Development, Tokyo, 157-8535, Japan.
Shun TakahashiCenter for Regenerative Medicine, National Center for Child Health and Development, Tokyo, 157-8535, Japan.
Kento ItoCenter for Regenerative Medicine, National Center for Child Health and Development, Tokyo, 157-8535, Japan.
Tomoo EtoCentral Institute for Experimental Medicine and Life Science, Kawasaki, 210-0821, Japan.
Toshiaki WatanabeCenter for Regenerative Medicine, National Center for Child Health and Development, Tokyo, 157-8535, Japan. watanabe-tos@ncchd.go.jp.

Funding

AMED JP19gm6310010AMED JP20gm6310010AMED JP21gm6310010AMED JP22gm6310010JST JPMJPR228BKAKENHI 20H03177KAKENHI 20H05764KAKENHI 22K18356
6 · The paper itself

Abstract

Germ cell transplantation is useful for the study of male germ cells and the generation of genetically modified animals. For transplantation, germ cell-free hosts generated using anticancer drug treatment, irradiation exposure, or genetic mutation are required. In this study, we aimed to develop a new system for germ cell depletion, more in compliance with the "3R" principles. For this purpose, we generated knock-in mice expressing a subtype of the herpes simplex virus type 1 thymidine kinase (HSV-TK30), reported to not induce infertility, unlike the original HSV-TK gene. Ganciclovir injection resulted in nearly complete abrogation of spermatogenesis. Furthermore, transplanted spermatogonial stem cells were differentiated into sperm in the host testes, and they gave rise to offspring. Therefore, the mice developed in this study enable the efficient removal of germ cells for germ cell transplantation in a manner more compliant with the 3R principles.

Indexed as

Germ CellsHerpesvirus 1, HumanTestisThymidine KinaseAnimalsGanciclovirGene Knock-In TechniquesMaleMiceMice, TransgenicSpermatogenesisGanciclovirThymidine KinaseDDX4Germ cell transplantationHost miceHSV-TKpiRNAPIWI-piRNASpermatogonial stem cellsTestesVasa

Identifiers

PMID40113830
PMCPMC11926112

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.